title: Chemotherapy and radiotherapy. When to call it quits.
abstract: BACKGROUND
  Patients diagnosed with cancer are often treated with chemotherapy and radiotherapy with curative intent. The transition from curative to palliative intent involves re-evaluation of treatment, and has to take into account the attitudes, beliefs and life aims of the patient.
  
  
  OBJECTIVE
  To discuss the difficulties in determining when to cease chemotherapy and radiotherapy in patients with advanced cancer.
  
  
  CONCLUSIONS
  The concept of treatment evaluation using a 'burden versus benefit' paradigm is discussed. Treatment aims must be in concordance with those of the patient, which are often couched in functional terms or linked to future significant life events. Chemotherapy and radiotherapy can offer patients in the palliative phase of cancer illness, benefits in terms of relief of symptoms and meaningful prolongation of life, and should be considered in appropriate circumstances.
authors.affiliation: University of Queensland Centre for General Practice, Centre for Palliative Care Education and Research, Queensland, Australia. g.mitchell@sph.uq.edu.au
authors.forename: Geoff
authors.initials: G
authors.lastname: Mitchell
authors.forename: David
authors.initials: D
authors.lastname: Currow
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D003657:Decision Making; D005194:Family Practice; D006801:Humans; D018447:Medical Futility; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D010166:Palliative Care; D011878:Radiotherapy / Q000009:adverse effects
chemical_list: D000970:Antineoplastic Agents